Insmed Incorporated (INSM) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026PRNewsWire • 09/03/26
Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?Zacks Investment Research • 08/27/26
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung DiseasePRNewsWire • 08/24/26
Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri UptakeZacks Investment Research • 08/07/26
Insmed Catapults 30%, Leading A Biotech Rally; But Mirum Takes A BathInvestors Business Daily • 08/06/26
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePRNewsWire • 08/06/26
Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/30/26
Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026PRNewsWire • 07/23/26